Facilitating T1 Translational Aging Research: Preclinical and Early Phase Human Studies (UG3/UH3 Clinical Trial Optional)
The National Institute on Aging (NIA) is offering a grant for research on translational aging, focusing on developing new treatments for aging-related conditions like sarcopenia and heart failure. Two types of projects are eligible: traditional drug development and computational drug repurposing. Traditional projects can start at different stages, from screening to clinical trials, while drug …
This Notice of Funding Opportunity (NOFO) from the National Institute on Aging (NIA) invites applications on T1 translational aging research (i.e., bench to bedside) which focus on advancing new therapeutics from preclinical stages to first-in-human (FIH) trials for aging-related conditions such…
Funding Source
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers